Celularity (CELU) Preferred Shares (2025)
Celularity (CELU) posted quarterly Preferred Shares of $2.2 million for Q4 2025.
Celularity (CELU) Preferred Shares (2025) Analysis & Trends
Celularity (CELU) has reported Preferred Shares for 1 consecutive years, with $2.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Preferred Shares changed N/A year-over-year to $2.2 million; the TTM figure through Dec 2025 stood at $2.2 million (changed N/A YoY), while the FY2025 annual figure was $2.2 million, changed N/A from the prior year.
- Preferred Shares held at $2.2 million in Q4 2025 per CELU's latest filing.
- Across five years, Preferred Shares topped out at $2.2 million in Q4 2025 and bottomed at $2.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Celularity | 21.37 Mn | 15.20 Mn | -3.27 Mn | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.22 Mn |